Φορτώνει......
Antiarrhythmic drug therapy for atrial fibrillation: Are the guidelines guiding clinical practice?
The AFFIRM study showed no clear survival advantage for a rhythm versus rate control strategy in patients with atrial fibrillation (AF). However, rhythm control with antiarrhythmic drugs (AADs) is appropriate in a large number of patients with AF. The American College of Cardiology/American Heart As...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Clin Cardiol |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Wiley Periodicals, Inc.
2006
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6654140/ https://ncbi.nlm.nih.gov/pubmed/16596830 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960290303 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|